PSM bookmarks

15935 bookmarks
Custom sorting
Statement From Canada's Acting Ambassador To the United States on U.S. Importation of Pharmaceutical Drugs from Canada, December 18, 2019
Statement From Canada's Acting Ambassador To the United States on U.S. Importation of Pharmaceutical Drugs from Canada, December 18, 2019
“While safe and secure, the Canadian market is too small to have a real impact on U.S. drug prices. The U.S. consumes 44% of the global prescription drug supply, compared to Canada’s 2%.”
·connect2canada.com·
Statement From Canada's Acting Ambassador To the United States on U.S. Importation of Pharmaceutical Drugs from Canada, December 18, 2019
APhA Alarmed by HHS/FDA Drug Importation Plans, American Pharmacist's Association, December 18, 2019
APhA Alarmed by HHS/FDA Drug Importation Plans, American Pharmacist's Association, December 18, 2019
"Today's proposal undermines the DSCSA's protections by introducing unsecure foreign prescription drug packages into our drug supply and commingling them with secure FDA-approved products. The lack of clarity around unknown, unproven cost savings does not justify jeopardizing U.S. supply chain integrity and patient safety."
·prnewswire.com·
APhA Alarmed by HHS/FDA Drug Importation Plans, American Pharmacist's Association, December 18, 2019
Pharmacy Associations Offer Perspective on Canada Drug Import Proposal, Drug Topics, December 20, 2019
Pharmacy Associations Offer Perspective on Canada Drug Import Proposal, Drug Topics, December 20, 2019
American Society of Health-System Pharmacists "has long been opposed to importing drugs from Canada due to safety concerns. 'One of our main concerns with the safety of importation is potentially bypassing safety requirements intended to protect against contaminated or counterfeit medications."”
·drugtopics.com·
Pharmacy Associations Offer Perspective on Canada Drug Import Proposal, Drug Topics, December 20, 2019
Importation Scheme Will Jeopardize Patient Health, Do Little to Lower Drug Costs, BIO, December 18, 2019
Importation Scheme Will Jeopardize Patient Health, Do Little to Lower Drug Costs, BIO, December 18, 2019
“Patients deserve access to the medicines they need with out-of-pocket costs they can afford. Under no circumstance should we risk patient safety to achieve this goal, yet that’s exactly what this dangerous importation scheme will do."
·bio.org·
Importation Scheme Will Jeopardize Patient Health, Do Little to Lower Drug Costs, BIO, December 18, 2019